These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23458763)

  • 21. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species.
    Poirel L; Bonnin RA; Nordmann P
    IUBMB Life; 2011 Dec; 63(12):1061-7. PubMed ID: 21990280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment options for multidrug-resistant nonfermenters.
    Briceño DF; Quinn JP; Villegas MV
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):303-15. PubMed ID: 20192684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.
    Mastoraki A; Douka E; Kriaras I; Stravopodis G; Saroglou G; Geroulanos S
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1086-90. PubMed ID: 18339553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance for multidrug-resistant Acinetobacter baumannii: a lesson on definitions.
    Ho PL; Ho AY; Chow KH; Cheng VC
    Int J Antimicrob Agents; 2010 Nov; 36(5):469-71. PubMed ID: 20727720
    [No Abstract]   [Full Text] [Related]  

  • 25. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
    Zavascki AP; Carvalhaes CG; Picão RC; Gales AC
    Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiresistant Acinetobacter baumannii infections: epidemiology and management.
    Garnacho-Montero J; Amaya-Villar R
    Curr Opin Infect Dis; 2010 Aug; 23(4):332-9. PubMed ID: 20581674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection prevention control bundle of multidrug-resistant Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus: which one is more important?
    Apisarnthanarak A; Mundy LM
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):207-8. PubMed ID: 24442090
    [No Abstract]   [Full Text] [Related]  

  • 28. Patterns of resolution of infectious parameters in multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Myrianthefs P; Ioannides K; Gavala A; Evodia E; Tsakris A; Baltopoulos G
    J Hosp Infect; 2010 May; 75(1):79-80. PubMed ID: 20303615
    [No Abstract]   [Full Text] [Related]  

  • 29. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
    Kempf M; Rolain JM
    Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Community-acquired necrotizing fasciitis caused by Acinetobacter baumannii].
    Hachimi MA; Rafik R; Elkartouti A; Louzi L; Hanafi SM; Mahmoudi A
    Ann Dermatol Venereol; 2013; 140(6-7):468-70. PubMed ID: 23773750
    [No Abstract]   [Full Text] [Related]  

  • 31. Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalised patients in Greece and treatment implications.
    Falagas ME; Mourtzoukou EG; Polemis M; Vatopoulos AC;
    Clin Microbiol Infect; 2007 Aug; 13(8):816-9. PubMed ID: 17610601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic discovery of synergistic novel antibiotic combinations targeting multidrug-resistant Acinetobacter baumannii.
    Chopra S; Matsuyama K; Tran T; Madrid P
    Int J Antimicrob Agents; 2012 Oct; 40(4):377-9. PubMed ID: 22858372
    [No Abstract]   [Full Text] [Related]  

  • 33. Aortic root abscess caused by multidrug-resistant Acinetobacter baumannii and treated with medical therapy only: A case report.
    Tseng HW; Chen GJ; Lu CC; Pan SC; Chen YS; Chang SC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):417-418. PubMed ID: 28778594
    [No Abstract]   [Full Text] [Related]  

  • 34. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
    Maragakis LL; Perl TM
    Clin Infect Dis; 2008 Apr; 46(8):1254-63. PubMed ID: 18444865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance.
    Dejsirilert S; Tiengrim S; Sawanpanyalert P; Aswapokee N; Malathum K
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S34-45. PubMed ID: 21294501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.
    Capone A; D'Arezzo S; Visca P; Petrosillo N;
    J Antimicrob Chemother; 2008 Aug; 62(2):422-3. PubMed ID: 18424790
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic options for Acinetobacter baumannii infections: an update.
    Vila J; Pachón J
    Expert Opin Pharmacother; 2012 Nov; 13(16):2319-36. PubMed ID: 23035697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meningitis with multidrug-resistant Acinetobacter baumannii treated with ampicillin/sulbactam.
    Kendirli T; Aydín HI; Hacíhamdioğlu D; Gülgün M; Unay B; Akín R; Lenk MK; Gökçay E
    J Hosp Infect; 2004 Apr; 56(4):328. PubMed ID: 15066747
    [No Abstract]   [Full Text] [Related]  

  • 39. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kwa AL; Loh C; Low JG; Kurup A; Tam VH
    Clin Infect Dis; 2005 Sep; 41(5):754-7. PubMed ID: 16080101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal therapy for multidrug-resistant Acinetobacter baumannii.
    Cunha BA
    Emerg Infect Dis; 2010 Jan; 16(1):170; author reply 170-1. PubMed ID: 20031080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.